Reduced Stent Strategy Versus Conventional Percutaneous Coronary Revascularization in Patients Presenting With STEMI

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1272 participants.

Also called NCT06353594

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,272 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06353594
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06353594. Randomized; no masking; primary purpose treatment. Start 2024-03-11 (actual); primary completion 2026-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Reduced Stent Strategy Versus Conventional Percutaneous Coronary Revascularization in Patients Presenting With STEMI
Acronym
COPERNICAN
Condition
ST Elevation Myocardial Infarction
Intervention (Device)
Primary PCI (percutaneous coronary intervention)
Lead sponsor
Hospital Universitario La Fe (class: other)
Collaborator
ERA4Health (class: not stated)

Record details

Record id
cardio:ct-nct06353594
Content hash
c0dc0caec705bc3ea959eefbc6d8d93f38e47a7e4bf1a1ecdbcc865219e564ce